Prebiotics

Any nondigestible food component that stimulates the growth and/or activity of bacteria in ways claimed to be beneficial to health.

LUX TAKE:

Ingredients that enhance the health of the human gut microflora, namely prebiotics and probiotics, will become further integrated into diversified food and beverage formats. As this occurs, ingredient manufacturers and CPGs should look to capitalize on three major trends occuring within the prebiotics space: 1) Effectiveness at lower doses is a key differentiator, 2) prebiotics with inherent ...

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent prebiotics developments.

News Commentaries

Better Juice forms partnership with Citrosuco to develop low-sugar orange juice (August 2, 2019)

Evonik and Perstorp partner to develop antibiotic alternatives using the animal microbiome (July 19, 2019)

New Lux Content

OptiBiotix (July 10, 2019)

Biohm (July 2, 2019)

New Patents

Computing...

New Investment Rounds

Computing...

Categories	Prebiotics
Related companies	BioActor, OptiBiotix, Inbiose, Jennewein Biotechnologie, MicroBiome Therapeutics, KFSU, Blue Prairie Brands, Natural Evolution Foods, Sugarlogix, Greenteaspoon, Food First, ReGrained, Prenexus Health, Carbiotix, Uplift Food, Yofix Probiotics, Embion Technologies, ISOThrive, Glycosyn LLC, Green Spot Technologies, Whole Biome

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978